{"id":4093,"date":"2023-03-28T16:47:11","date_gmt":"2023-03-28T20:47:11","guid":{"rendered":"https:\/\/icam-cimu.ca\/?post_type=sessions&p=4093"},"modified":"2023-03-28T16:47:11","modified_gmt":"2023-03-28T20:47:11","slug":"hr-p-57-developing-combination-therapies-for-telomerase-overexpressing-clear-cell-carcinoma-of-the-ovaries","status":"publish","type":"sessions","link":"https:\/\/icam-cimu.ca\/fr\/sessions\/hr-p-57-developing-combination-therapies-for-telomerase-overexpressing-clear-cell-carcinoma-of-the-ovaries\/","title":{"rendered":"HR-P-57 | Developing combination therapies for telomerase-overexpressing clear cell carcinoma of the ovaries"},"template":"","accreditation":[60],"speakers":[],"session-themes":[37],"sessions":[32],"class_list":["post-4093","sessions","type-sessions","status-publish","hentry","accreditation-non-accredited","session-themes-health-research","sessions-poster-sessions"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/icam-cimu.ca\/fr\/wp-json\/wp\/v2\/sessions\/4093"}],"collection":[{"href":"https:\/\/icam-cimu.ca\/fr\/wp-json\/wp\/v2\/sessions"}],"about":[{"href":"https:\/\/icam-cimu.ca\/fr\/wp-json\/wp\/v2\/types\/sessions"}],"wp:attachment":[{"href":"https:\/\/icam-cimu.ca\/fr\/wp-json\/wp\/v2\/media?parent=4093"}],"wp:term":[{"taxonomy":"accreditation","embeddable":true,"href":"https:\/\/icam-cimu.ca\/fr\/wp-json\/wp\/v2\/accreditation?post=4093"},{"taxonomy":"speakers","embeddable":true,"href":"https:\/\/icam-cimu.ca\/fr\/wp-json\/wp\/v2\/speakers?post=4093"},{"taxonomy":"session-themes","embeddable":true,"href":"https:\/\/icam-cimu.ca\/fr\/wp-json\/wp\/v2\/session-themes?post=4093"},{"taxonomy":"sessions","embeddable":true,"href":"https:\/\/icam-cimu.ca\/fr\/wp-json\/wp\/v2\/sessions?post=4093"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}